News
A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce ...
For our most recent episode of the Fourcast we’ve been speaking to controversial British cardiologist Aseem Malhotra, who was recently appointed as a senior advisor to the US Health Secretary. That ...
GlobalData analysts have tipped the global market for genomic therapies to balloon to almost $90 billion by 2030, driven by ...
Morabaha Marina Financing Co. (MRNA) said it will not be able to release its preliminary financial results for the ...
A study from Karolinska Institutet reveals how cells adapt to nutrient scarcity by altering their genetic instructions. This ...
Klothea Bio Inc., a biotechnology company pioneering mRNA-based therapies to upregulate the anti-aging protein Klotho, today announced its ongoing collaboration with Healthy Longevity Clinic (HLC), ...
One of the most commonly used gene-delivery methods relies on engineered viruses to insert stretches of genetic material into a cell’s genome. Although effective, these viruses tend to insert their ...
StockStory.org on MSN1d
MRNA Q1 Earnings Call: Management Focuses on Cost Reductions and Pipeline Progress Amid Revenue ShortfallBiotechnology company Moderna (NASDAQ:MRNA) in Q1 CY2025, with sales falling 35.3% year on year to $108 million. The ...
Learn more about whether Kymera Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades ...
Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting ...
Misinformation about ivermectin took hold during the Covid-19 pandemic and continues to circulate despite medical experts ...
Krishnan Guru-Murthy: The mainstream opinion doesn’t share this view. They think, they say, ‘it’s obvious – look at the deaths from Covid, it is clear that the vaccine did more good than harm.’ Yes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results